PG
PMC

PEAK6 Group’s PharMerica Corporation PMC Stock Holding History

PEAK6 Group’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,400
Closed -$95K – 5355
2016
Q3 		$95K Buy
+3,400
New +$87.2K ﹤0.01% 3603

Other funds holding PMC

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PEAK6 Group's PMC Position: Q4 2016 in Review

PEAK6 Group sold out of PharMerica Corporation (PMC) in Q4 2016, closing a stake of 456 shares — an estimated $13K sold.

PEAK6 Group first reported a position in PMC in Q3 2016 and held it in 1 quarter. The position peaked at $13K in Q3 2016. 166 funds tracked by Wall St. Rank hold PMC as of Q4 2016.

  • PEAK6 Group reported no remaining PharMerica Corporation position as of Q4 2016 after selling out during the quarter.
  • PEAK6 Group sold 456 PharMerica Corporation shares in Q4 2016, an estimated $13K.
  • PEAK6 Group first reported a position in PharMerica Corporation in Q3 2016 and held it in 1 quarter.
  • PEAK6 Group's PharMerica Corporation position peaked at $13K in Q3 2016.
  • 166 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2016.

Based on PEAK6 Group's 13F filing for Q4 2016, filed 13 Feb 2017.